Any defect in one or more genes that affect the nervous system can lead to a neurogenetic disorder. Neurogenetic testing is a test for neurogenetic disorders such as dementia, inherited neuropathies, Parkinson's disease, epilepsy, and more.
This report contains market size and forecasts of Neurogenetic Testing in Global, including the following market information:
Global Neurogenetic Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Neurogenetic Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
MRI Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Neurogenetic Testing include Labcorp, Pacific Biosciences of California, Victorian Clinical Genetics Services, MedGenome Labs, Blueprint Genetics, GeneDx, Mayo Clinic and Neurogene, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Neurogenetic Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neurogenetic Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Neurogenetic Testing Market Segment Percentages, by Type, 2021 (%)
MRI
Next Generation Sequencing
Multiplex Ligation-dependent Probe Amplification (MLPA)
Fragment Analysis PCR
Global Neurogenetic Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Neurogenetic Testing Market Segment Percentages, by Application, 2021 (%)
Hospitals
Specialty Clinics
Research Institutes
Diagnostics Laboratories
Global Neurogenetic Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Neurogenetic Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Neurogenetic Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Neurogenetic Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Labcorp
Pacific Biosciences of California
Victorian Clinical Genetics Services
MedGenome Labs
Blueprint Genetics
GeneDx
Mayo Clinic
Neurogene